Protect Yourself from Dangerous Drug Reactions Before Starting HIV Treatment
Starting HIV medication should bring hope, not hidden risks. If you’re about to begin Abacavir-based treatment, this genetic test could be the difference between successful therapy and life-threatening complications. We understand the anxiety around new medications – that’s why we offer this essential screening to ensure your treatment journey begins safely.
What This Life-Saving Test Reveals
The HLA Hypersensitivity to Abacavir test detects whether you carry the HLA-B*5701 gene variant. This isn’t just medical information – it’s personal protection. When people with this gene take Abacavir, their immune system can react violently, causing severe skin reactions, organ damage, and in some cases, fatal outcomes. Our advanced PCR and sequencing technology provides 99.9% accuracy, giving you and your doctor the certainty needed for safe treatment decisions.
Who Absolutely Needs This Protection?
This test is essential if you’re:
- Starting or considering Abacavir-containing HIV treatment (like Ziagen or Kivexa)
- Experiencing unexplained fever, rash, or fatigue during HIV therapy
- Concerned about medication safety and potential allergic reactions
- Living in South Africa’s diverse genetic population where HLA variations are common
- Wanting peace of mind before committing to long-term HIV treatment
Don’t wait for symptoms to appear – prevention is always better than treatment when it comes to drug hypersensitivity.
Why This Test Matters for Your Health Journey
Knowing your HLA-B*5701 status empowers you with:
- Life-saving prevention – Avoid potentially fatal allergic reactions before they happen
- Treatment confidence – Start HIV medication knowing it’s safe for your genetic makeup
- Peace of mind – Eliminate the worry about unexpected drug reactions
- Better outcomes – Work with your doctor to choose the most effective, safest treatment
- Cost savings – Prevent expensive emergency treatments and hospitalisations
Understanding Your Results – Clear Guidance, No Confusion
We make understanding your results simple and reassuring:
- Negative Result: Great news! You can safely use Abacavir-containing medications without hypersensitivity risk
- Positive Result: Important protection! Your doctor will choose alternative HIV treatments that work safely with your genetics
Every result comes with clear explanations and next-step guidance. Our medical team is available to answer any questions – you’re never alone in understanding your health information.
Affordable Protection for Your Health
| Test Option | Regular Price | Special Price | Value |
|---|---|---|---|
| HLA Hypersensitivity to Abacavir Test | ZAR 2,700 | Save ZAR 1,300 |
Consider this: A single emergency room visit for drug reaction treatment can cost thousands more than this preventive test. This small investment protects against potentially massive medical costs and, more importantly, protects your health.
Why South Africans Trust Oracle Genomics
- Nationwide Coverage – Available in Johannesburg, Cape Town, Durban, Pretoria and across South Africa
- Medical Expertise – Working with physicians and HIV specialists nationwide
- Accuracy Guarantee – 99.9% accurate results using advanced PCR and sequencing technology
- Fast Turnaround – Results in 10-12 days, not weeks
- Simple Testing – Just a blood sample or buccal swab, no special preparation needed
- Complete Confidentiality – Your genetic information is protected with strict privacy standards
Take Control of Your Treatment Safety Today
Don’t leave your medication safety to chance. This simple test could prevent serious health complications and give you the confidence to move forward with your HIV treatment journey.
Limited Time Special: Save ZAR 1,300 on this essential genetic screening. Price increases to ZAR 4,000 soon.
Convenient Options: Book online, visit our Johannesburg, Cape Town or Durban locations, or arrange mobile testing.
Your health journey deserves to begin with confidence, not concern. Let us help you take this important step toward safer HIV treatment.
